Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,966 | 6,305 | 7,214 | 5,641 | 6,990 |
| Receivables | 7,810 | 168 | 87 | 57 | 84 |
| TOTAL | $21,418 | $7,667 | $8,104 | $6,221 | $7,426 |
| Non-Current Assets | |||||
| PPE Net | 16 | 15 | 15 | 20 | 25 |
| Intangibles | 2,433 | 2,458 | 2,484 | 2,509 | 0 |
| Other Non-Current Assets | 134 | 150 | 160 | 173 | 182 |
| TOTAL | $2,583 | $2,623 | $2,658 | $2,702 | $207 |
| Total Assets | $24,002 | $10,291 | $10,762 | $8,923 | $7,633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,543 | 832 | 1,460 | 916 | 516 |
| TOTAL | $4,620 | $906 | $1,530 | $983 | $579 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 109 | 127 | 124 | 140 | 123 |
| TOTAL | $109 | $127 | $124 | $140 | $123 |
| Total Liabilities | $4,729 | $1,033 | $1,654 | $1,123 | $702 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,894 | 1,579 | 1,504 | 1,345 | 1,266 |
| Common Shares | 34,603 | 21,697 | 18,501 | 14,785 | 14,733 |
| Retained earnings | -18,050 | -15,784 | -13,133 | -11,100 | -9,319 |
| Other shareholders' equity | -194 | -184 | -287 | -295 | -364 |
| TOTAL | $19,273 | $9,257 | $9,108 | $7,800 | $6,931 |
| Total Liabilities And Equity | $24,002 | $10,291 | $10,762 | $8,923 | $7,633 |